University Medical Centre Ljubljana, Ljubljana (Slovenia)
1
follower
8
more
presentations
in this session
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results
Testing for iron deficiency and use of ferric carboxymaltose in patients with heart failure: need for implementation? data from the swedish heart failure registry